CIK 0001325618 · Non-accelerated filer<br>Smaller reporting company
IRADIMED CORP
Sign in to watch- Ticker
- IRMD
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 731408526
- Phone
- 4076778022
- Business address
- 12705 INGENUITY DRIVE, ORLANDO, FL, 32826
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $122,622
- in 1 filing
Net −$122,622. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-06 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −4,800 | $71.70 | $344K | 2,342,700 |
| 2025-10-06 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −200 | $72.27 | $14K | 2,342,500 |
| 2025-10-01 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −1,123 | $69.20 | $78K | 2,351,377 |
| 2025-10-01 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −3,448 | $70.41 | $243K | 2,347,929 |
| 2025-10-01 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −429 | $71.03 | $30K | 2,347,500 |
| 2025-09-23 | KIANI JOE E Director | Grant or award · Restricted Stock Units | +2,095 | 2,095 | ||
| 2025-09-23 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −5,000 | $71.26 | $356K | 2,352,500 |
| 2025-09-17 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −3,454 | $71.00 | $245K | 2,359,046 |
| 2025-09-17 | Susi Roger E. CEO, PRESIDENT, CHAIRMAN | Sale 10b5-1 | −1,546 | $71.88 | $111K | 2,357,500 |
| 2025-08-06 | ALLEN MONTY K Director | Sale | −1,102 | $69.10 | $76K | 19,898 |
| 2025-06-20 | GLENN JOHN CHIEF FINANCIAL OFFICER | Option exercise | +5,796 | 14,563 | ||
| 2025-06-20 | GLENN JOHN CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,412 | $58.24 | $82K | 13,151 |
| 2025-06-20 | GLENN JOHN CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −5,796 | 5,796 | ||
| 2024-12-11 | Chiprin Jeff Chief Commercial Officer | Grant or award · Restricted Stock Units | +2,990 | 2,990 | ||
| 2024-12-11 | Chiprin Jeff Chief Commercial Officer | Grant or award · Performance-based Restricted Stock Units | +2,989 | 2,989 | ||
| 2024-12-11 | VUOTO ANTHONY Director | Grant or award · Restricted Stock Units | +1,811 | 3,008 | ||
| 2024-12-11 | Scharen-Guivel Hilda Frederique Director | Grant or award · Restricted Stock Units | +1,811 | 3,008 | ||
| 2024-12-11 | ALLEN MONTY K Director | Grant or award · Restricted Stock Units | +1,811 | 3,008 | ||
| 2024-12-11 | HAWKINS JAMES B Director | Grant or award · Restricted Stock Units | +1,811 | 3,008 | ||
| 2024-12-11 | GLENN JOHN CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +5,436 | 40,508 |
Page 9 of 14 · 275 trades